Related Experiment Videos
[Concomitant immunity against Sarcoma E 100 comparing 2 strains of rats]
M L Bay1, G Didoli, L A Urizar
1Departamento de Ciencias Fisiológicas, Facultad de Ciencias Médicas, Universidad Nacional de Rosario, Argentina.
Medicina
|January 1, 1994
Summary
Host factors influence concomitant immunity (IC), the ability of tumor-bearing animals to inhibit a second tumor challenge. This study investigated IC in two rat lines, revealing distinct immune responses and tumor inhibition mechanisms.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Concomitant immunity (IC) describes a tumor-bearing host's ability to reject a subsequent tumor challenge.
- The host's contribution to IC development remains incompletely understood, particularly in distinct genetic backgrounds.
- Investigating IC mechanisms is crucial for developing novel cancer immunotherapies.
Purpose of the Study:
- To elucidate the host's role in establishing concomitant immunity (IC).
- To compare IC induction in two rat lines (IIMc and 'm') with differential Sarcoma E 100 (SE 100) tumor behaviors.
- To determine if IC relies on immunological mechanisms or tumor-derived factors.
Main Methods:
- Two rat lines (IIMc: high regression; 'm': high take/death) were inoculated with Sarcoma E 100 (SE 100).
- Rats received a second SE 100 challenge at different time points (days 3, 7, 14) post-initial inoculation.
- Winn assays were performed using spleen cells from tumor-bearing or immune rats to assess immunocompetence.
Main Results:
- Reinoculation on day 7 significantly decreased tumor take percentage and surface area in both rat lines.
- Rats of line IIMc exhibited reduced primary tumor development and demonstrated immunocompetent spleen cells against SE 100.
- Line 'm' rats showed limited immunization (10%) and smaller tumor take percentages only when co-inoculated with immune spleen cells, suggesting non-immunological factors.
Conclusions:
- Concomitant immunity in IIMc rats is attributed to host immunological mechanisms.
- In line 'm' rats, IC appears to be mediated by factors released or induced by the primary tumor.
- Host genetic background significantly influences the mechanisms underlying concomitant immunity.